首页 > 最新文献

Archives of Osteoporosis最新文献

英文 中文
Dietary acidity and bone mass in minority children and adolescents: a cross-sectional analysis from the MetA-Bone trial
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-28 DOI: 10.1007/s11657-025-01497-5
Ashley Petrie, Maria Angélica Trak-Fellermeier, Jacqueline Hernandez, Alison Macchi, Preciosa Martinez-Motta, Rodolfo Galván, Yolangel Hernandez, Rebeca Martinez, Cristina Palacios

Summary

Dietary acid load could be associated with bone mass, but there are limited and conflicting results. This secondary cross-sectional analysis evaluated these associations among 123 children/adolescents, mostly Hispanics. Dietary acid load seems to be associated with bone mass in boys, but these results should be confirmed through long-term studies.

Background

Childhood/adolescence is key for developing strong bones. With the continuing rise in osteoporosis rates in Western societies, attention has turned to the possible impact of diets that create high levels of acid in the body. Some studies have shown an association between dietary acid load and bone mass, but there are limited studies in children/adolescents and none in Hispanics.

Objective

This study aimed to evaluate the associations between dietary acid load (assessed as dietary potential renal acid load, PRAL, and protein to potassium ratio) and whole-body bone mineral content (BMC) and density (BMD) in a sample of 123 children and adolescents of predominantly Hispanic ethnicity.

Design

This study is a secondary cross-sectional analysis.

Results

Dietary PRAL was positively associated with BMC and BMD overall (p < 0.05) and with BMC in boys (p < 0.05) when adjusted for energy misreporting only. The vegetable protein to potassium ratio was inversely associated with BMC (p = 0.004) in boys only, after adjusting for important factors.

Conclusions

Dietary acid load seems to be associated with BMC in boys in this sample of primarily Hispanic children. Long-term studies are needed to confirm these results and to understand the importance of protein intake in relation to other key nutrients in bone mass acquisition among Hispanic boys.

{"title":"Dietary acidity and bone mass in minority children and adolescents: a cross-sectional analysis from the MetA-Bone trial","authors":"Ashley Petrie,&nbsp;Maria Angélica Trak-Fellermeier,&nbsp;Jacqueline Hernandez,&nbsp;Alison Macchi,&nbsp;Preciosa Martinez-Motta,&nbsp;Rodolfo Galván,&nbsp;Yolangel Hernandez,&nbsp;Rebeca Martinez,&nbsp;Cristina Palacios","doi":"10.1007/s11657-025-01497-5","DOIUrl":"10.1007/s11657-025-01497-5","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>Dietary acid load could be associated with bone mass, but there are limited and conflicting results. This secondary cross-sectional analysis evaluated these associations among 123 children/adolescents, mostly Hispanics. Dietary acid load seems to be associated with bone mass in boys, but these results should be confirmed through long-term studies.</p><h3>Background</h3><p>Childhood/adolescence is key for developing strong bones. With the continuing rise in osteoporosis rates in Western societies, attention has turned to the possible impact of diets that create high levels of acid in the body. Some studies have shown an association between dietary acid load and bone mass, but there are limited studies in children/adolescents and none in Hispanics.</p><h3>Objective</h3><p>This study aimed to evaluate the associations between dietary acid load (assessed as dietary potential renal acid load, PRAL, and protein to potassium ratio) and whole-body bone mineral content (BMC) and density (BMD) in a sample of 123 children and adolescents of predominantly Hispanic ethnicity.</p><h3>Design</h3><p>This study is a secondary cross-sectional analysis.</p><h3>Results</h3><p>Dietary PRAL was positively associated with BMC and BMD overall (<i>p</i> &lt; 0.05) and with BMC in boys (<i>p</i> &lt; 0.05) when adjusted for energy misreporting only. The vegetable protein to potassium ratio was inversely associated with BMC (<i>p</i> = 0.004) in boys only, after adjusting for important factors.</p><h3>Conclusions</h3><p>Dietary acid load seems to be associated with BMC in boys in this sample of primarily Hispanic children. Long-term studies are needed to confirm these results and to understand the importance of protein intake in relation to other key nutrients in bone mass acquisition among Hispanic boys.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-01-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143057872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lee’s TRIAD—osteoporosis, fragility fracture, and bone health optimization
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-23 DOI: 10.1007/s11657-024-01482-4
Joon-Kiong Lee

Summary

Osteoporosis, fragility fractures, and bone health optimization share the same pathophysiology, diagnostic tools, risk assessment, and treatments. Grouping them into “Lee’s TRIAD” allows surgeons and physicians to collaborate more efficiently, using unified principles and strategies for managing these conditions.

Purpose

The primary goal of osteoporosis management is to prevent fragility fractures, which occur from falls from standing height or less in individuals over fifty. However, the management of bone health optimization is often neglected in patients undergoing elective surgeries, such as arthroplasty and spinal surgeries. The objective of this article is to link all these three conditions into a TRIAD so that surgeons and physicians can collaborate more effectively, utilizing similar principles and strategies for better management.

Methodology

Clinical approaches based on country-specific guidelines are commonly used to manage osteoporosis. However, skeletal assessments are rarely conducted before or after elective procedures, leading to overlooked conditions such as osteoporosis, osteopenia, and fragility fracture risk factors. These three conditions are illustrated from the patient case study shown, to highlight the importance of not neglecting bone health optimization in high risk individuals undergoing elective surgery, with underlying osteopenia and multiple risk factors who sustained fragility fracture intraoperatively.

Result

Patients undergoing elective surgeries often have their bone health neglected, leading to a higher incidence of complications such as aseptic loosening and peri-prosthetic fractures due to poor bone quality and density. Bone health assessment and optimization therefore is essential in patients with osteoporosis, osteopenia with clinical risk factors, and patients with history of fragility fracture, to ensure implants sit on bone with good density and quality to minimize the complications.

Conclusion

By combining osteoporosis, fragility fractures, and bone health optimization into a TRIAD, “Lee’s TRIAD,” surgeons and physicians can collaborate more effectively, utilizing similar principles and strategies for better management.

{"title":"Lee’s TRIAD—osteoporosis, fragility fracture, and bone health optimization","authors":"Joon-Kiong Lee","doi":"10.1007/s11657-024-01482-4","DOIUrl":"10.1007/s11657-024-01482-4","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>Osteoporosis, fragility fractures, and bone health optimization share the same pathophysiology, diagnostic tools, risk assessment, and treatments. Grouping them into “Lee’s TRIAD” allows surgeons and physicians to collaborate more efficiently, using unified principles and strategies for managing these conditions.</p><h3>Purpose</h3><p>The primary goal of osteoporosis management is to prevent fragility fractures, which occur from falls from standing height or less in individuals over fifty. However, the management of bone health optimization is often neglected in patients undergoing elective surgeries, such as arthroplasty and spinal surgeries. The objective of this article is to link all these three conditions into a TRIAD so that surgeons and physicians can collaborate more effectively, utilizing similar principles and strategies for better management.</p><h3>Methodology</h3><p>Clinical approaches based on country-specific guidelines are commonly used to manage osteoporosis. However, skeletal assessments are rarely conducted before or after elective procedures, leading to overlooked conditions such as osteoporosis, osteopenia, and fragility fracture risk factors. These three conditions are illustrated from the patient case study shown, to highlight the importance of not neglecting bone health optimization in high risk individuals undergoing elective surgery, with underlying osteopenia and multiple risk factors who sustained fragility fracture intraoperatively.</p><h3>Result</h3><p>Patients undergoing elective surgeries often have their bone health neglected, leading to a higher incidence of complications such as aseptic loosening and peri-prosthetic fractures due to poor bone quality and density. Bone health assessment and optimization therefore is essential in patients with osteoporosis, osteopenia with clinical risk factors, and patients with history of fragility fracture, to ensure implants sit on bone with good density and quality to minimize the complications.</p><h3>Conclusion</h3><p>By combining osteoporosis, fragility fractures, and bone health optimization into a TRIAD, “Lee’s TRIAD,” surgeons and physicians can collaborate more effectively, utilizing similar principles and strategies for better management.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143021991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of using grip strength and hand muscle cross-sectional area to predict secondary fractures post distal radius fracture 用握力和手部肌肉截面积预测桡骨远端骨折后继发骨折的评价
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-16 DOI: 10.1007/s11657-024-01465-5
Matthew Tsz Kin Kong, Christian Fang, Colin Shing Yat Yung, Theresa Kwok, Keith Leung, Frankie Leung

Summary

Grip strength measurement, as a surrogate of sarcopenia diagnosis, effectively predicts secondary fracture risk in distal radius fracture patients. This simple tool enhances clinical practice by identifying high-risk patients for targeted interventions, potentially preventing or reversing functional decline and recurrent fractures.

Purpose

To evaluate grip strength and hand muscle cross-sectional area as predictors of secondary fracture risk in patients with a history of distal radius fracture (DRF), serving as surrogates of the diagnosis of sarcopenia.

Methods

A retrospective cohort study of 745 DRF patients was analyzed with their grip strength data using Cox proportional hazards regression, receiver operating characteristic analysis, and Kaplan–Meier analysis to predict secondary fracture risk over an average of 12 years. Hand muscle cross-sectional area was similarly analyzed.

Results

Patients with a history of DRF were predicted to have a 4.1% higher likelihood of experiencing a secondary fracture per kilogram reduction in their grip strength (p < 0.008), independent of age and sex. Patients were categorized as high-risk (≤ 16 kg), moderate-risk (17–24 kg), or low–risk (≥ 25 kg) (p < 0.001). High-risk patients showed a 2.2-fold (95% CI = 1.55–3.17) higher recurrent fracture risk compared to low-risk patients. Cumulative secondary fracture probabilities of the high-risk group patients at 5, 10, and 15 years were estimated to be 16%, 30%, and 54%, respectively.

Conclusions

Grip strength measurement, as a surrogate of sarcopenia diagnosis, effectively predicts secondary fracture risk in patients with DRF. This simple tool could improve clinical practice by identifying high-risk patients for targeted interventions to prevent recurrent fractures or even reverse functional decline.

握力测量作为肌肉减少症诊断的替代指标,可有效预测桡骨远端骨折患者继发骨折的风险。这个简单的工具通过识别高风险患者进行有针对性的干预来增强临床实践,潜在地预防或逆转功能衰退和复发性骨折。目的评价有桡骨远端骨折(DRF)病史患者的握力和手部肌肉截面积作为继发性骨折风险的预测指标,作为肌肉减少症的诊断指标。方法对745例DRF患者进行回顾性队列研究,采用Cox比例风险回归、受试者操作特征分析和Kaplan-Meier分析,预测平均12年的二次骨折风险。对手部肌肉横截面积进行类似分析。结果预测有DRF病史的患者在握力每公斤降低时发生二次骨折的可能性高出4.1% (p < 0.008),与年龄和性别无关。患者被分为高危(≤16 kg)、中危(17-24 kg)和低危(≥25 kg) (p < 0.001)。与低危患者相比,高危患者骨折复发风险高2.2倍(95% CI = 1.55-3.17)。高危组患者在5年、10年和15年的累积继发性骨折概率分别估计为16%、30%和54%。结论握力测量可作为肌肉减少症诊断的替代指标,有效预测DRF患者继发骨折风险。这个简单的工具可以通过识别高风险患者进行有针对性的干预来改善临床实践,以防止复发性骨折甚至逆转功能衰退。
{"title":"Evaluation of using grip strength and hand muscle cross-sectional area to predict secondary fractures post distal radius fracture","authors":"Matthew Tsz Kin Kong,&nbsp;Christian Fang,&nbsp;Colin Shing Yat Yung,&nbsp;Theresa Kwok,&nbsp;Keith Leung,&nbsp;Frankie Leung","doi":"10.1007/s11657-024-01465-5","DOIUrl":"10.1007/s11657-024-01465-5","url":null,"abstract":"<div><h3>Summary</h3><p>Grip strength measurement, as a surrogate of sarcopenia diagnosis, effectively predicts secondary fracture risk in distal radius fracture patients. This simple tool enhances clinical practice by identifying high-risk patients for targeted interventions, potentially preventing or reversing functional decline and recurrent fractures.</p><h3>Purpose</h3><p>To evaluate grip strength and hand muscle cross-sectional area as predictors of secondary fracture risk in patients with a history of distal radius fracture (DRF), serving as surrogates of the diagnosis of sarcopenia.</p><h3>Methods</h3><p>A retrospective cohort study of 745 DRF patients was analyzed with their grip strength data using Cox proportional hazards regression, receiver operating characteristic analysis, and Kaplan–Meier analysis to predict secondary fracture risk over an average of 12 years. Hand muscle cross-sectional area was similarly analyzed.</p><h3>Results</h3><p>Patients with a history of DRF were predicted to have a 4.1% higher likelihood of experiencing a secondary fracture per kilogram reduction in their grip strength (<i>p</i> &lt; 0.008), independent of age and sex. Patients were categorized as high-risk (≤ 16 kg), moderate-risk (17–24 kg), or low–risk (≥ 25 kg) (<i>p</i> &lt; 0.001). High-risk patients showed a 2.2-fold (95% CI = 1.55–3.17) higher recurrent fracture risk compared to low-risk patients. Cumulative secondary fracture probabilities of the high-risk group patients at 5, 10, and 15 years were estimated to be 16%, 30%, and 54%, respectively.</p><h3>Conclusions</h3><p>Grip strength measurement, as a surrogate of sarcopenia diagnosis, effectively predicts secondary fracture risk in patients with DRF. This simple tool could improve clinical practice by identifying high-risk patients for targeted interventions to prevent recurrent fractures or even reverse functional decline.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11657-024-01465-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142994486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patient perceptions of osteoporosis management: a qualitative pilot study by a patient advisory group 患者对骨质疏松管理的看法:一项由患者咨询小组进行的定性初步研究。
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-15 DOI: 10.1007/s11657-024-01486-0
R. M. Javier, F. Debiais, F. Alliot-Launois, D. Poivret, P. Bosgiraud, F. Barbe, M. Bouyssié, M. Devert, F. Roux, M. P. Sacchi, S. Sirot, P. Halbout, T. Chevalley, J. Y. Reginster, B. Cortet

Summary

The management of osteoporosis even after a fracture is declining. Our pilot study in patients with osteoporosis confirms a large ignorance of the disease and major fears and uncertainties about the treatments. Complete and sustained medical information seems essential to counteract the contradictory information, which are exclusively negative.

Purpose

The management of osteoporosis (OP) even after a fracture has declined over recent years despite the actions of the medical societies concerned with this disease. The objective of this pilot study was to investigate patients’ perceptions of OP, their treatment pathways, and how information is obtained.

Methods

The Association Française de Lutte Anti-Rhumatismale (AFLAR) constituted an advisory group of 7 French patients (mean age 63.7 years [54–74 years]), with various stages of OP and duration of disease. A qualitative, anonymized study was conducted with an open-ended semi-structured questionnaire, with a contribution of the International Osteoporosis Foundation (IOF) and the “Groupe de Recherche et Informations sur les Ostéoporoses” (GRIO).

Results

The onset of OP was often sudden, with the fracture occurring in a context of deep misunderstanding of OP by both the public and physicians. The patients have confidence in the physician, mostly a rheumatologist, who informs about OP and initiates the treatment. The main cause of non-adherence being major fears and uncertainties about efficacy and safety of treatments. Medical information is considered as insufficient, or poorly understood. Negative information has the highest impact, even if the sources seem unreliable, such as media. There is no trust in pharmaceutical companies and the ethics of physicians are in question.

Conclusion

This IOF/GRIO/AFLAR Patient Advisory Group pilot study illustrates the numerous barriers to effective OP management. Complete and sustained medical information, especially at the time of diagnosis and initiation of treatment, seems essential to counteract the contradictory information, which are exclusively negative.

即使在骨折后,骨质疏松症的治疗也在下降。我们对骨质疏松症患者的初步研究证实了对这种疾病的大量无知,以及对治疗的主要恐惧和不确定性。完整和持续的医疗信息似乎对抵消完全消极的相互矛盾的信息至关重要。目的:骨折后骨质疏松症(OP)的治疗近年来有所下降,尽管医学协会对这种疾病采取了行动。这项初步研究的目的是调查患者对OP的看法,他们的治疗途径,以及如何获得信息。方法:法国抗风湿病协会(AFLAR)组成了一个咨询小组,7名法国患者(平均年龄63.7岁[54-74岁]),不同阶段的OP和病程。在国际骨质疏松基金会(IOF)和“研究和信息组织”(GRIO)的协助下,采用开放式半结构化问卷进行了一项定性的匿名研究。结果:OP的发病往往是突然的,骨折发生在公众和医生对OP的深刻误解的背景下。患者对医生(主要是风湿病学家)有信心,他们会告知OP并开始治疗。不坚持治疗的主要原因是对治疗的有效性和安全性的严重恐惧和不确定。医学信息被认为是不充分的,或者理解得很差。负面信息的影响最大,即使其来源看起来不可靠,比如媒体。人们对制药公司没有信任,医生的职业道德也受到质疑。结论:IOF/GRIO/AFLAR患者咨询小组的初步研究表明,有效的OP管理存在许多障碍。完整和持续的医疗信息,特别是在诊断和开始治疗时,似乎对抵消完全消极的相互矛盾的信息至关重要。
{"title":"Patient perceptions of osteoporosis management: a qualitative pilot study by a patient advisory group","authors":"R. M. Javier,&nbsp;F. Debiais,&nbsp;F. Alliot-Launois,&nbsp;D. Poivret,&nbsp;P. Bosgiraud,&nbsp;F. Barbe,&nbsp;M. Bouyssié,&nbsp;M. Devert,&nbsp;F. Roux,&nbsp;M. P. Sacchi,&nbsp;S. Sirot,&nbsp;P. Halbout,&nbsp;T. Chevalley,&nbsp;J. Y. Reginster,&nbsp;B. Cortet","doi":"10.1007/s11657-024-01486-0","DOIUrl":"10.1007/s11657-024-01486-0","url":null,"abstract":"<div><h3>Summary</h3><p>The management of osteoporosis even after a fracture is declining. Our pilot study in patients with osteoporosis confirms a large ignorance of the disease and major fears and uncertainties about the treatments. Complete and sustained medical information seems essential to counteract the contradictory information, which are exclusively negative.</p><h3>Purpose</h3><p>The management of osteoporosis (OP) even after a fracture has declined over recent years despite the actions of the medical societies concerned with this disease. The objective of this pilot study was to investigate patients’ perceptions of OP, their treatment pathways, and how information is obtained.</p><h3>Methods</h3><p>The Association Française de Lutte Anti-Rhumatismale (AFLAR) constituted an advisory group of 7 French patients (mean age 63.7 years [54–74 years]), with various stages of OP and duration of disease. A qualitative, anonymized study was conducted with an open-ended semi-structured questionnaire, with a contribution of the International Osteoporosis Foundation (IOF) and the “Groupe de Recherche et Informations sur les Ostéoporoses” (GRIO).</p><h3>Results</h3><p>The onset of OP was often sudden, with the fracture occurring in a context of deep misunderstanding of OP by both the public and physicians. The patients have confidence in the physician, mostly a rheumatologist, who informs about OP and initiates the treatment. The main cause of non-adherence being major fears and uncertainties about efficacy and safety of treatments. Medical information is considered as insufficient, or poorly understood. Negative information has the highest impact, even if the sources seem unreliable, such as media. There is no trust in pharmaceutical companies and the ethics of physicians are in question.</p><h3>Conclusion</h3><p>This IOF/GRIO/AFLAR Patient Advisory Group pilot study illustrates the numerous barriers to effective OP management. Complete and sustained medical information, especially at the time of diagnosis and initiation of treatment, seems essential to counteract the contradictory information, which are exclusively negative.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11657-024-01486-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142982384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The development and implementation of a digital platform in a fracture liaison service 裂缝联络服务中数字平台的开发与实现
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-08 DOI: 10.1007/s11657-024-01491-3
Bernadette Conlon, Helen O’Brien, Vanessa Clarke

Summary

The fracture liaison service in the study hospital developed and successfully implemented a digital platform to support the identification of patients while concurrently optimizing participation in the National Fracture Liaison Database. This initiative provides additional evidence of the capacity of digital health to support fracture liaison services.

Purpose

Resourced fracture liaison services (FLSs) are accepted internationally as the preeminent means of reducing the risk of future fragility fractures. The FLS in the study hospital sought to develop and implement a digital platform to support the identification of patients and concurrently effectively participate in the National Fracture Liaison Service Database (FLS-DB) established to monitor key performance indicators (KPIs).

Method

Through linkage with the already established hospital’s eTrauma digital system and Inpatient Management System, a bespoke fracture liaison digital platform was developed and introduced. Platform functionality supports automated patient identification and interoperability with the National Fracture Liaison Service Database enabling the anonymized safe transfer of key performance indicator data.

Results

Through automated identification of patients who require fracture liaison services, rates of identification have improved from 10% in 2021 to 87%. Time previously spent manually identifying patients is now available for clinical care. Key performance indicator data are recorded as part of the assessment and treatment process and successfully anonymized and transferred to the national database.

Conclusion

This initiative provides additional evidence of the capacity of digital health to support fracture liaison services. In comparable settings nationally and internationally where there are coexisting digital systems to support patient management and a national digital database for FLS key performance indicators, there is potential for the successful introduction of similar FLS digital platforms.

研究医院的骨折联络服务开发并成功实施了一个数字平台,以支持患者的识别,同时优化国家骨折联络数据库的参与。这一举措为数字医疗支持骨折联络服务的能力提供了额外证据。目的资源骨折联络服务(FLSs)是国际上公认的降低未来易碎性骨折风险的卓越手段。研究医院的FLS试图开发和实施一个数字平台,以支持患者的识别,同时有效地参与为监测关键绩效指标(kpi)而建立的国家骨折联络服务数据库(FLS- db)。方法通过与已建立的医院电子创伤数字化系统和住院病人管理系统的联动,开发并引入定制化骨折联络数字化平台。平台功能支持患者自动识别和与国家骨折联络服务数据库的互操作性,实现关键性能指标数据的匿名安全传输。结果通过自动识别需要骨折连接服务的患者,识别率从2021年的10%提高到87%。以前花在人工识别患者上的时间现在可用于临床护理。关键绩效指标数据作为评估和处理过程的一部分被记录下来,并成功地匿名化并转移到国家数据库。这一举措为数字健康支持骨折联络服务的能力提供了额外的证据。在国内和国际可比较的环境中,存在共存的数字系统来支持患者管理和FLS关键绩效指标的国家数字数据库,有可能成功引入类似的FLS数字平台。
{"title":"The development and implementation of a digital platform in a fracture liaison service","authors":"Bernadette Conlon,&nbsp;Helen O’Brien,&nbsp;Vanessa Clarke","doi":"10.1007/s11657-024-01491-3","DOIUrl":"10.1007/s11657-024-01491-3","url":null,"abstract":"<div><h3>Summary</h3><p>The fracture liaison service in the study hospital developed and successfully implemented a digital platform to support the identification of patients while concurrently optimizing participation in the National Fracture Liaison Database. This initiative provides additional evidence of the capacity of digital health to support fracture liaison services.</p><h3>Purpose</h3><p>Resourced fracture liaison services (FLSs) are accepted internationally as the preeminent means of reducing the risk of future fragility fractures. The FLS in the study hospital sought to develop and implement a digital platform to support the identification of patients and concurrently effectively participate in the National Fracture Liaison Service Database (FLS-DB) established to monitor key performance indicators (KPIs).</p><h3>Method</h3><p>Through linkage with the already established hospital’s eTrauma digital system and Inpatient Management System, a bespoke fracture liaison digital platform was developed and introduced. Platform functionality supports automated patient identification and interoperability with the National Fracture Liaison Service Database enabling the anonymized safe transfer of key performance indicator data.</p><h3>Results</h3><p>Through automated identification of patients who require fracture liaison services, rates of identification have improved from 10% in 2021 to 87%. Time previously spent manually identifying patients is now available for clinical care. Key performance indicator data are recorded as part of the assessment and treatment process and successfully anonymized and transferred to the national database.</p><h3>Conclusion</h3><p>This initiative provides additional evidence of the capacity of digital health to support fracture liaison services. In comparable settings nationally and internationally where there are coexisting digital systems to support patient management and a national digital database for FLS key performance indicators, there is potential for the successful introduction of similar FLS digital platforms.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142938849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trends in osteoporosis assessment, diagnosis after fragility fractures, and treatment for hospitalized patients with osteoporosis or fragility fractures between 2012 and 2021 2012年至2021年间骨质疏松评估、脆性骨折后诊断和住院骨质疏松或脆性骨折患者治疗的趋势
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-01-08 DOI: 10.1007/s11657-024-01492-2
Wenhui Zeng, Wei Liu, Lulu Zhang, Yiping Zhang, Yuxiang He, Weijuan Su, Peiying Huang, Caoxin Huang, Mingzhu Lin, Xuejun Li, Xiulin Shi

Summary

Our study investigated trends in osteoporosis management in Xiamen from 2012 to 2021, revealing improvements in screening and treatment, although medication use remained low. Additionally, we identified factors that may influence medication use and emphasized the importance of effective osteoporosis management strategies.

Purpose

The goal of the current study is to explore trends in assessment, diagnosis after fragility fractures, and osteoporosis treatment among hospitalized patients in Xiamen, China, between 2012 and 2021.

Methods

We conducted a retrospective cross-sectional study, using the Cochran-Armitage trend test to describe trends. Logistic regression was performed to identify the influencing factors of anti-osteoporosis medication (AOM) treatment. We performed a sensitivity analysis to verify the robustness of our findings.

Results

From 2012 to 2021, the rates of dual-energy X-ray absorptiometry (DXA) scans and bone turnover marker (BTM) examinations increased from 0 to 37% and 36.5%, respectively. 29.3% of patients with fragility fractures were diagnosed with osteoporosis. The use rate of AOM was only 22.7%. There was an upward trend in the prescription of bisphosphonates, increasing from 1% in 2012 to 16.8% in 2021. The use of calcitonin ranged from 4.1% (2014) to 32.7% (2021). Calcium and vitamin D supplementation prescribing increased significantly from 5.6% in 2012 to 78.7% in 2021. Logistic regression analysis showed that old age, female sex, history of fractures, DXA scans, and osteoporosis diagnosis were significantly associated with increased AOM use. Tobacco use, hypertension, diabetes, congestive heart failure, cerebral vascular accidents, and severe liver diseases were associated with a reduced likelihood of AOM treatment.

Conclusions

Although assessment, diagnosis after fragility fractures, and osteoporosis treatment have increased over the past decade, there are still deficiencies in the management of osteoporosis. In the future, it will be necessary to further strengthen management of osteoporosis.

您的研究调查了2012年至2021年厦门市骨质疏松症管理的趋势,揭示了筛查和治疗的改善,尽管药物使用率仍然很低。此外,我们确定了可能影响药物使用的因素,并强调了有效的骨质疏松症管理策略的重要性。本研究的目的是探讨2012年至2021年中国厦门住院患者脆性骨折后的评估、诊断和骨质疏松症治疗的趋势。方法采用回顾性横断面研究,采用Cochran-Armitage趋势检验来描述趋势。采用Logistic回归分析抗骨质疏松药物治疗的影响因素。我们进行了敏感性分析来验证我们发现的稳健性。结果2012 - 2021年,双能x线吸收仪(DXA)扫描率和骨转换标志物(BTM)检查率分别从0上升到37%和36.5%。29.3%的脆性骨折患者诊断为骨质疏松。AOM的使用率仅为22.7%。双膦酸盐处方呈上升趋势,从2012年的1%上升到2021年的16.8%。降钙素的使用范围从4.1%(2014年)到32.7%(2021年)。钙和维生素D补充剂处方从2012年的5.6%大幅增加到2021年的78.7%。Logistic回归分析显示,年龄、女性、骨折史、DXA扫描和骨质疏松症诊断与AOM使用增加显著相关。吸烟、高血压、糖尿病、充血性心力衰竭、脑血管意外和严重肝脏疾病与AOM治疗可能性降低有关。结论近十年来,尽管脆弱性骨折后的评估、诊断和骨质疏松治疗有所增加,但在骨质疏松的管理方面仍存在不足。今后,进一步加强对骨质疏松症的管理是必要的。
{"title":"Trends in osteoporosis assessment, diagnosis after fragility fractures, and treatment for hospitalized patients with osteoporosis or fragility fractures between 2012 and 2021","authors":"Wenhui Zeng,&nbsp;Wei Liu,&nbsp;Lulu Zhang,&nbsp;Yiping Zhang,&nbsp;Yuxiang He,&nbsp;Weijuan Su,&nbsp;Peiying Huang,&nbsp;Caoxin Huang,&nbsp;Mingzhu Lin,&nbsp;Xuejun Li,&nbsp;Xiulin Shi","doi":"10.1007/s11657-024-01492-2","DOIUrl":"10.1007/s11657-024-01492-2","url":null,"abstract":"<div><h3>Summary</h3><p>Our study investigated trends in osteoporosis management in Xiamen from 2012 to 2021, revealing improvements in screening and treatment, although medication use remained low. Additionally, we identified factors that may influence medication use and emphasized the importance of effective osteoporosis management strategies.</p><h3>Purpose</h3><p>The goal of the current study is to explore trends in assessment, diagnosis after fragility fractures, and osteoporosis treatment among hospitalized patients in Xiamen, China, between 2012 and 2021.</p><h3>Methods</h3><p>We conducted a retrospective cross-sectional study, using the Cochran-Armitage trend test to describe trends. Logistic regression was performed to identify the influencing factors of anti-osteoporosis medication (AOM) treatment. We performed a sensitivity analysis to verify the robustness of our findings.</p><h3>Results</h3><p>From 2012 to 2021, the rates of dual-energy X-ray absorptiometry (DXA) scans and bone turnover marker (BTM) examinations increased from 0 to 37% and 36.5%, respectively. 29.3% of patients with fragility fractures were diagnosed with osteoporosis. The use rate of AOM was only 22.7%. There was an upward trend in the prescription of bisphosphonates, increasing from 1% in 2012 to 16.8% in 2021. The use of calcitonin ranged from 4.1% (2014) to 32.7% (2021). Calcium and vitamin D supplementation prescribing increased significantly from 5.6% in 2012 to 78.7% in 2021. Logistic regression analysis showed that old age, female sex, history of fractures, DXA scans, and osteoporosis diagnosis were significantly associated with increased AOM use. Tobacco use, hypertension, diabetes, congestive heart failure, cerebral vascular accidents, and severe liver diseases were associated with a reduced likelihood of AOM treatment.</p><h3>Conclusions</h3><p>Although assessment, diagnosis after fragility fractures, and osteoporosis treatment have increased over the past decade, there are still deficiencies in the management of osteoporosis. In the future, it will be necessary to further strengthen management of osteoporosis.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142938918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of the FRAX® tool and its adjustments in women living with diabetes: a cohort study in primary care in Brazil FRAX®工具在女性糖尿病患者中的使用及其调整:巴西初级保健队列研究
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-31 DOI: 10.1007/s11657-024-01489-x
Fernando Meireles de Oliveira, Rafaela Martinez Copês Leal, Fabio Vasconcellos Comim, Melissa Orlandin Premaor

Summary

The FRAX® algorithm showed good accuracy in women living with DM followed in primary care. There were no differences between the ROC curve with and without adjustments for major and hip fractures. The FRAX® 10-year and FRAX® AR were better calibrated in this population.

Purpose

An increased risk of fractures in people living with diabetes has been described. Screening instruments to calculate this risk have been proposed, including the FRAX® algorithm. Some studies suggest that minor modifications to this instrument can improve its performance. These modifications work well in other countries, but we do not know if they work in Brazil. The objective of our study was to evaluate the performance of the FRAX® algorithm with and without adjustments for women living with DM (WLDM) in primary care in Brazil.

Methods

A cohort study that included post-menopausal women attending primary care in Santa Maria, Brazil, was conducted from 2013 to 2018. The risk for major and hip fractures was calculated using the FRAX® tool. The FRAX® risk was calculated: (1) without adjustments (unadjusted FRAX®); (2) increasing the entered age by 10 years in individuals with DM (FRAX® 10 years); and (3) inserting the diagnosis of DM as rheumatoid arthritis (FRAX® AR).

Results

The accuracy for major fracture was 0.948 (unadjusted FRAX®), 0.947 (FRAX® 10 years), and 0.946 (FRAX® AR). For hip fractures, the accuracies were 0.989 (unadjusted FRAX®), 0.988 (FRAX® 10 years), and 0.988 (FRAX® AR). Furthermore, there were no differences between the area under the ROC curve with and without adjustments for major and hip fractures. Conversely, the FRAX® 10 years and the FRAX® AR were better calibrated, presenting a lower Chi-square.

Conclusion

The FRAX® algorithm showed good accuracy in WLDM followed in primary care. The FRAX® 10 years and FRAX® AR were better calibrated in this population.

FRAX®算法在糖尿病患者的初级保健随访中显示出良好的准确性。对于大骨折和髋部骨折,经调整和未调整的ROC曲线之间没有差异。在该人群中,FRAX®10年和FRAX®AR的校准效果更好。目的:糖尿病患者骨折风险增加。已经提出了用于计算该风险的筛选工具,包括FRAX®算法。一些研究表明,对这台仪器稍加修改就可以提高它的性能。这些修改在其他国家很有效,但我们不知道它们在巴西是否有效。本研究的目的是评估FRAX®算法在巴西初级保健中对患有糖尿病(WLDM)的妇女进行调整和不进行调整的性能。方法2013年至2018年在巴西圣玛丽亚进行了一项队列研究,纳入了在初级保健中心就诊的绝经后妇女。使用FRAX®工具计算大骨折和髋部骨折的风险。FRAX®风险计算:(1)未经调整(未调整的FRAX®);(2) DM患者的入组年龄延长10年(FRAX®延长10年);(3)将DM诊断为类风湿关节炎(rheumatoid arthritis, FRAX®AR)。结果主要骨折的准确率分别为0.948(未调整FRAX®)、0.947 (FRAX®10年)和0.946 (FRAX®AR)。对于髋部骨折,准确率分别为0.989(未调整FRAX®)、0.988 (FRAX®10年)和0.988 (FRAX®AR)。此外,对于大骨折和髋部骨折,经过调整和没有调整的ROC曲线下面积之间没有差异。相反,FRAX®10年和FRAX®AR的校准效果更好,卡方值更低。结论FRAX®算法在初级保健WLDM随访中具有良好的准确性。在该人群中,FRAX®10年和FRAX®AR的校准效果更好。
{"title":"The use of the FRAX® tool and its adjustments in women living with diabetes: a cohort study in primary care in Brazil","authors":"Fernando Meireles de Oliveira,&nbsp;Rafaela Martinez Copês Leal,&nbsp;Fabio Vasconcellos Comim,&nbsp;Melissa Orlandin Premaor","doi":"10.1007/s11657-024-01489-x","DOIUrl":"10.1007/s11657-024-01489-x","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>The FRAX® algorithm showed good accuracy in women living with DM followed in primary care. There were no differences between the ROC curve with and without adjustments for major and hip fractures. The FRAX® 10-year and FRAX® AR were better calibrated in this population.</p><h3>Purpose</h3><p>An increased risk of fractures in people living with diabetes has been described. Screening instruments to calculate this risk have been proposed, including the FRAX® algorithm. Some studies suggest that minor modifications to this instrument can improve its performance. These modifications work well in other countries, but we do not know if they work in Brazil. The objective of our study was to evaluate the performance of the FRAX® algorithm with and without adjustments for women living with DM (WLDM) in primary care in Brazil.</p><h3>Methods</h3><p>A cohort study that included post-menopausal women attending primary care in Santa Maria, Brazil, was conducted from 2013 to 2018. The risk for major and hip fractures was calculated using the FRAX® tool. The FRAX® risk was calculated: (1) without adjustments (unadjusted FRAX®); (2) increasing the entered age by 10 years in individuals with DM (FRAX® 10 years); and (3) inserting the diagnosis of DM as rheumatoid arthritis (FRAX® AR).</p><h3>Results</h3><p>The accuracy for major fracture was 0.948 (unadjusted FRAX®), 0.947 (FRAX® 10 years), and 0.946 (FRAX® AR). For hip fractures, the accuracies were 0.989 (unadjusted FRAX®), 0.988 (FRAX® 10 years), and 0.988 (FRAX® AR). Furthermore, there were no differences between the area under the ROC curve with and without adjustments for major and hip fractures. Conversely, the FRAX® 10 years and the FRAX® AR were better calibrated, presenting a lower Chi-square.</p><h3>Conclusion</h3><p>The FRAX® algorithm showed good accuracy in WLDM followed in primary care. The FRAX® 10 years and FRAX® AR were better calibrated in this population.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142906123","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rare association between ankylosing spondylitis and paget’s disease: A case of pagetic vertebral ankylosis 强直性脊柱炎与paget病的罕见关联:1例pagetic椎体强直
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-27 DOI: 10.1007/s11657-024-01490-4
Celil Barlas Cengiz, Melih Kızıltepe, Hüseyin Kaplan, Emel Oğuz Kökoğlu, Tuğba Kahraman Denizhan, Abdurrahman Soner Şenel

Paget’s disease is a condition marked by abnormal bone remodeling, involving both excessive bone formation and destruction, predominantly in the elderly. Pagetic vertebral ankylosis is a rare manifestation, often associated with Paget’s disease, ankylosing spondylitis, or diffuse idiopathic skeletal hyperostosis. This form of acquired vertebral ankylosis is uncommon and occurs in cases with bone-bridging syndesmophytes or osteophytes. Here, we present a case of delayed diagnosis of Paget’s disease in the lower vertebral column, progressing to cervicothoracic vertebral ankylosis secondary to ankylosing spondylitis.

佩吉特病是一种以异常骨重塑为特征的疾病,包括过度的骨形成和破坏,主要发生在老年人身上。Pagetic椎体强直是一种罕见的表现,通常与Paget病、强直性脊柱炎或弥漫性特发性骨骼增生有关。这种形式的获得性椎体强直不常见,发生在骨桥综合征或骨赘的病例中。在这里,我们提出一个延迟诊断的下脊柱Paget病的病例,进展为继发于强直性脊柱炎的颈胸椎强直。
{"title":"Rare association between ankylosing spondylitis and paget’s disease: A case of pagetic vertebral ankylosis","authors":"Celil Barlas Cengiz,&nbsp;Melih Kızıltepe,&nbsp;Hüseyin Kaplan,&nbsp;Emel Oğuz Kökoğlu,&nbsp;Tuğba Kahraman Denizhan,&nbsp;Abdurrahman Soner Şenel","doi":"10.1007/s11657-024-01490-4","DOIUrl":"10.1007/s11657-024-01490-4","url":null,"abstract":"<div><p>Paget’s disease is a condition marked by abnormal bone remodeling, involving both excessive bone formation and destruction, predominantly in the elderly. Pagetic vertebral ankylosis is a rare manifestation, often associated with Paget’s disease, ankylosing spondylitis, or diffuse idiopathic skeletal hyperostosis. This form of acquired vertebral ankylosis is uncommon and occurs in cases with bone-bridging syndesmophytes or osteophytes. Here, we present a case of delayed diagnosis of Paget’s disease in the lower vertebral column, progressing to cervicothoracic vertebral ankylosis secondary to ankylosing spondylitis.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142889495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of excluding fractured or abnormal vertebrae on the trabecular bone score measurement 排除骨折或异常椎体对小梁骨评分测量的影响
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-27 DOI: 10.1007/s11657-024-01485-1
Yen-Huai Lin, Michael Mu Huo Teng

Summary

Brief rationale: The use of L1–L4 vertebrae, without exclusions, has been recommended for trabecular bone score (TBS) measurements.

Main result: Excluding abnormal and fractured vertebrae affected the TBS.

Significance of the paper: Fracture or degenerative abnormality may not affect TBS. The preferred action may involve including all levels without exclusions.

Purpose

The use of L1–L4 vertebrae, without exclusions, has been recommended for trabecular bone score (TBS) measurements. We aimed to investigate the effect of excluding fractured or abnormal vertebrae from TBS.

Methods

Dual-energy X-ray absorptiometry images of 2767 participants, including 1080 without excluded vertebrae, 556 with fractured vertebrae, and 1131 with abnormal vertebrae showing a 1.0 T-score difference compared to the adjacent vertebrae, were retrospectively reviewed. Differences between TBS measurements with and without fractured or abnormal vertebrae were evaluated.

Results

Among 1080 participants without excluded vertebrae, TBS was 1.234 at L1, 1.296 at L2, 1.308 at L3, and 1.301 at L4. A significantly higher mean TBS was seen after excluding L1, whereas a significantly lower mean TBS was seen after excluding L2–L4. In the 556 participants with fractured vertebrae, excluding the involved level from the TBS calculation led to a significant difference in the total sample, women, ≥ 70 years old, and overweight subgroups. A significantly higher mean TBS was seen after excluding the fractured L1, whereas a significantly lower mean TBS was seen after excluding fractures at L2–L4. Among the 1131 participants with abnormal vertebrae, excluding the involved level from the TBS led to a significant difference in age, sex, and body mass index subgroups. Excluding abnormal L1 and L4 vertebrae led to a significantly higher and lower mean TBS, respectively.

Conclusion

Excluding fractured or abnormal vertebrae led to differences in TBS across various subgroups. Regarding the effect of vertebral level exclusion, the observed differences may be attributed to the systematic intervertebral variation, which is unrelated to any effect from fractures or degenerative abnormalities.

简要原理:推荐使用L1-L4椎体,不排除,用于小梁骨评分(TBS)测量。主要结果:排除影响TBS的异常椎体和骨折椎体。本文意义:骨折或退行性异常不影响TBS。首选的行动可能包括所有级别,没有排除。目的不排除使用L1-L4椎体进行骨小梁评分(TBS)测量。我们的目的是探讨在TBS中排除骨折或异常椎体的效果。方法回顾性分析2767例患者的双能x线吸收图像,其中1080例未排除椎体,556例骨折椎体,1131例异常椎体,与相邻椎体相比t评分差异为1.0。评估有无骨折或异常椎体的TBS测量差异。结果在未排除椎骨的1080名受试者中,L1、L2、L3和L4的TBS分别为1.234、1.296、1.308和1.301。排除L1后,平均TBS显著升高,而排除L2-L4后,平均TBS显著降低。在556名椎骨骨折的参与者中,从TBS计算中排除受累水平会导致总样本、女性、≥70岁和超重亚组的显著差异。排除L1骨折后,平均TBS明显升高,而排除L2-L4骨折后,平均TBS明显降低。在1131名椎骨异常的参与者中,从TBS中排除受累水平会导致年龄、性别和体重指数亚组的显著差异。排除异常的L1和L4椎体导致TBS平均值分别显著升高和降低。结论排除骨折或异常椎体导致不同亚组间TBS的差异。关于椎体水平排除的影响,观察到的差异可能归因于系统性椎间变异,而与骨折或退行性异常的影响无关。
{"title":"Effect of excluding fractured or abnormal vertebrae on the trabecular bone score measurement","authors":"Yen-Huai Lin,&nbsp;Michael Mu Huo Teng","doi":"10.1007/s11657-024-01485-1","DOIUrl":"10.1007/s11657-024-01485-1","url":null,"abstract":"<div><h3>\u0000 <i>Summary</i>\u0000 </h3><p>Brief rationale: The use of L1–L4 vertebrae, without exclusions, has been recommended for trabecular bone score (TBS) measurements.</p><p>Main result: Excluding abnormal and fractured vertebrae affected the TBS.</p><p>Significance of the paper: Fracture or degenerative abnormality may not affect TBS. The preferred action may involve including all levels without exclusions.</p><h3>Purpose</h3><p>The use of L1–L4 vertebrae, without exclusions, has been recommended for trabecular bone score (TBS) measurements. We aimed to investigate the effect of excluding fractured or abnormal vertebrae from TBS.</p><h3>Methods</h3><p>Dual-energy X-ray absorptiometry images of 2767 participants, including 1080 without excluded vertebrae, 556 with fractured vertebrae, and 1131 with abnormal vertebrae showing a 1.0 T-score difference compared to the adjacent vertebrae, were retrospectively reviewed. Differences between TBS measurements with and without fractured or abnormal vertebrae were evaluated.</p><h3>Results</h3><p>Among 1080 participants without excluded vertebrae, TBS was 1.234 at L1, 1.296 at L2, 1.308 at L3, and 1.301 at L4. A significantly higher mean TBS was seen after excluding L1, whereas a significantly lower mean TBS was seen after excluding L2–L4. In the 556 participants with fractured vertebrae, excluding the involved level from the TBS calculation led to a significant difference in the total sample, women, ≥ 70 years old, and overweight subgroups. A significantly higher mean TBS was seen after excluding the fractured L1, whereas a significantly lower mean TBS was seen after excluding fractures at L2–L4. Among the 1131 participants with abnormal vertebrae, excluding the involved level from the TBS led to a significant difference in age, sex, and body mass index subgroups. Excluding abnormal L1 and L4 vertebrae led to a significantly higher and lower mean TBS, respectively.</p><h3>Conclusion</h3><p>Excluding fractured or abnormal vertebrae led to differences in TBS across various subgroups. Regarding the effect of vertebral level exclusion, the observed differences may be attributed to the systematic intervertebral variation, which is unrelated to any effect from fractures or degenerative abnormalities.\u0000</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s11657-024-01485-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142890462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of 12-week power training on bone in mobility-limited older adults: randomised controlled trial 12周力量训练对活动受限老年人骨骼的影响:随机对照试验
IF 3.1 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM Pub Date : 2024-12-27 DOI: 10.1007/s11657-024-01487-z
Valentina Muollo, Lars G. Hvid, Vikram V. Shanbhogue, Viktoria Steinhauser, Daniela Caporossi, Ivan Dimauro, Marianne Skovsager Andersen, Cristina Fantini, Elisa Grazioli, Elsa S. Strotmeyer, Paolo Caserotti

Summary

This study examines how power training affects estimated bone strength, revealing that females benefit more than males, especially in the upper limbs (radius). These findings highlight the importance of designing sex-specific exercise programs to enhance bone health. Further research is needed to optimize training duration and address site-specific differences.

Purpose

This study aimed to compare the effects of 12-week of power training (PWT), an explosive form of strength training, on bone microarchitecture, estimated bone strength, and markers in mobility-limited (gait speed < 0.9 m/s) older adults.

Methods

Fifty-seven older adults (83 ± 5 years) were randomly assigned to either a training group (TRAIN, n = 28, 15 females, 13 males) performing high-intensity PWT or a control group (CTRL, n = 29, 22 females, 7 males) maintaining their usual lifestyle. High-resolution peripheral quantitative computed tomography (HR-pQCT) assessed bone geometry, densities, microarchitecture (e.g. trabecular number (Tb.N) and thickness (Tb.Th)), and estimated bone strength (stiffness and failure load) at the tibia and radius. Blood markers for bone metabolism (PINP and CTX-1) and muscle strength (handgrip and leg press) were also measured.

Results

Baseline sex differences showed females having lower stiffness (− 37.5%) and failure load (− 38%) at the radius compared with males. After PWT, females in the TRAIN group exhibited declines in Tb.N (− 4.4%) and improvements in Tb.Th (+ 6.0%), stiffness (+ 2.7%), and failure load (+ 2.4%) at the radius (p < 0.05). A time x group interaction indicated increases in leg press strength for the whole TRAIN group (+ 23%), and within females (+ 29%) and males (+ 19%) (p < 0.001). Baseline handgrip strength correlated with stiffness (r = 0.577) and failure load (r = 0.612) at the radius (p < 0.001). Females in the TRAIN group showed a reduction in PINP (− 25%), while males showed an increase in CTX-1 (+ 18%).

Conclusion

A 12-week PWT may enhance estimated bone strength in mobility-limited older adults, especially at sites less accustomed to daily loading (i.e. radius).

Clinical trial registration

NCT02051725.

本研究考察了力量训练如何影响估计的骨强度,揭示了女性比男性受益更多,特别是在上肢(桡骨)。这些发现强调了设计针对不同性别的锻炼项目以增强骨骼健康的重要性。需要进一步的研究来优化培训时间和解决具体地点的差异。目的:本研究旨在比较12周力量训练(PWT)(一种爆发性力量训练形式)对骨微结构、估计骨强度和行动受限老年人(步态速度& 0.9 m/s)标志物的影响。方法将57名年龄为83±5岁的老年人随机分为高强度PWT训练组(TRAIN, n = 28,女性15,男性13)和对照组(CTRL, n = 29,女性22,男性7)。高分辨率外围定量计算机断层扫描(HR-pQCT)评估骨几何形状、密度、微结构(如小梁数(Tb.N)和厚度(Tb.Th)),并估计胫骨和桡骨的骨强度(刚度和破坏载荷)。还测量了骨代谢(PINP和CTX-1)和肌肉力量(握力和腿压)的血液标志物。结果基线性别差异显示,与男性相比,女性在桡骨处的刚度(- 37.5%)和破坏负荷(- 38%)较低。PWT后,TRAIN组的女性结核发病率下降。N(- 4.4%)和结核的改善。Th(+ 6.0%),刚度(+ 2.7%)和破坏载荷(+ 2.4%)半径(p & lt; 0.05)。时间x组相互作用表明,整个TRAIN组(+ 23%)以及女性(+ 29%)和男性(+ 19%)的腿压力量增加(p < 0.001)。基线握力与半径处的刚度(r = 0.577)和失效载荷(r = 0.612)相关(p < 0.001)。女性在TRAIN组显示PINP减少(- 25%),而男性显示CTX-1增加(+ 18%)。结论:12周PWT可提高行动受限老年人的预估骨强度,特别是在不习惯日常负荷的部位(如桡骨)。临床试验注册号nct02051725。
{"title":"Effects of 12-week power training on bone in mobility-limited older adults: randomised controlled trial","authors":"Valentina Muollo,&nbsp;Lars G. Hvid,&nbsp;Vikram V. Shanbhogue,&nbsp;Viktoria Steinhauser,&nbsp;Daniela Caporossi,&nbsp;Ivan Dimauro,&nbsp;Marianne Skovsager Andersen,&nbsp;Cristina Fantini,&nbsp;Elisa Grazioli,&nbsp;Elsa S. Strotmeyer,&nbsp;Paolo Caserotti","doi":"10.1007/s11657-024-01487-z","DOIUrl":"10.1007/s11657-024-01487-z","url":null,"abstract":"<div><h3>Summary</h3><p>This study examines how power training affects estimated bone strength, revealing that females benefit more than males, especially in the upper limbs (radius). These findings highlight the importance of designing sex-specific exercise programs to enhance bone health. Further research is needed to optimize training duration and address site-specific differences.</p><h3>Purpose</h3><p>This study aimed to compare the effects of 12-week of power training (PWT), an explosive form of strength training, on bone microarchitecture, estimated bone strength, and markers in mobility-limited (gait speed &lt; 0.9 m/s) older adults.</p><h3>Methods</h3><p>Fifty-seven older adults (83 ± 5 years) were randomly assigned to either a training group (TRAIN, <i>n</i> = 28, 15 females, 13 males) performing high-intensity PWT or a control group (CTRL, <i>n</i> = 29, 22 females, 7 males) maintaining their usual lifestyle. High-resolution peripheral quantitative computed tomography (HR-pQCT) assessed bone geometry, densities, microarchitecture (e.g. trabecular number (Tb.N) and thickness (Tb.Th)), and estimated bone strength (stiffness and failure load) at the tibia and radius. Blood markers for bone metabolism (PINP and CTX-1) and muscle strength (handgrip and leg press) were also measured.</p><h3>Results</h3><p>Baseline sex differences showed females having lower stiffness (− 37.5%) and failure load (− 38%) at the radius compared with males. After PWT, females in the TRAIN group exhibited declines in Tb.N (− 4.4%) and improvements in Tb.Th (+ 6.0%), stiffness (+ 2.7%), and failure load (+ 2.4%) at the radius (<i>p</i> &lt; 0.05). A time x group interaction indicated increases in leg press strength for the whole TRAIN group (+ 23%), and within females (+ 29%) and males (+ 19%) (<i>p</i> &lt; 0.001). Baseline handgrip strength correlated with stiffness (<i>r</i> = 0.577) and failure load (<i>r</i> = 0.612) at the radius (<i>p</i> &lt; 0.001). Females in the TRAIN group showed a reduction in PINP (− 25%), while males showed an increase in CTX-1 (+ 18%).</p><h3>Conclusion</h3><p>A 12-week PWT may enhance estimated bone strength in mobility-limited older adults, especially at sites less accustomed to daily loading (i.e. radius).</p><h3>Clinical trial registration</h3><p>NCT02051725.</p></div>","PeriodicalId":8283,"journal":{"name":"Archives of Osteoporosis","volume":"20 1","pages":""},"PeriodicalIF":3.1,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142890461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Osteoporosis
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1